Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
Status:
Completed
Trial end date:
2017-11-23
Target enrollment:
Participant gender:
Summary
Probiotics have been proposed as useful therapeutic alternatives for the treatment of
irritable bowel syndrome patients. Bacillus clausii is a probiotic that has been used for the
treatment of acute diarrhea among adults and pediatric patients, as well as an adjunctive
therapy for the treatment for Helicobacter pylori infection. It has been proposed that
Bacillus clausii is effective for the treatment of irritable bowel syndrome-related symptoms
(especially diarrhea and bloating) in non-controlled trials. The aim of the proposed
investigation is to determine whether the administration of Bacillus clausii during two weeks
plus dietary advice compared to antispasmodics plus dietary advice would be an effective and
safe alternative.